Karkinos Healthcare

08/04/2026

We reflect on a critical question: is precision medicine a luxury or necessity? At Karkinos Healthcare, we believe that biological insight should not be a privilege. The convergence of equity and precision means bringing the most advanced genomic tools to the grassroots level.

By decentralising cancer care and integrating Whole Genome Sequencing into standard clinical workflows, we can bridge the gap between urban centers and underserved regions. Equity is not just about access to care, it is about access to the right care, informed by the individual’s own DNA.

Join the conversation: https://www.karkinos.in/k-vani/the-convergence-of-equity-and-precision-redefining-the-cancer-journey/

07/04/2026

On World Health Day, we are reminded that advancing healthcare is, at its heart, a shared responsibility. This year’s theme by the World Health Organization, ‘Together for Health: Stand with Science,’ invites us to look beyond the treatment of illness and toward a future where systems are built on empathy, evidence, and equitable access.

At Karkinos Healthcare, we are committed to translating this vision into practice by integrating clinical excellence with data-driven insights and network-enabled, patient-centric care models across the continuum. Our approach synergises distribution care network, patient navigation, and precision diagnostics to establish coordinated care pathways that support both clinicians and patients in making informed decisions.

As we look ahead, our goal is to help ensure that advancements in healthcare are not confined by geography or cost, but serve as a bridge toward consistent care for all.

05/04/2026

Karkinos Healthcare wishes you and your loved ones a bright and joyful Easter.

30/03/2026

Karkinos Healthcare recently participated in the Colloquium on Inherited Arrhythmias & Arrhythmogenic Cardiomyopathy, a focused scientific forum convening experts to advance understanding in cardiovascular genetics. Organised by the Caritas Heart Institute and backed by the Kerala Heart Rhythm Society (KHRS), the platform enabled critical dialogue on the evolving role of genomics in cardiac care.

Dr. Vinod Scaria, Chief Data Officer, Karkinos Healthcare, highlighted the transformative potential of genomics in reshaping how high-risk cardiac conditions are identified and managed. His session explored the role of diverse genetic patterns in disease and brought forward structured testing approaches that can significantly elevate diagnostic precision while enabling sharper, risk-aligned clinical decisions.

We remain committed to embedding genomics into clinical pathways to enable more precise, evidence-led approaches to disease management and early intervention.

30/03/2026

Healthcare decisions are often influenced by cost—not just the immediate expense, but the long-term price of delayed diagnosis and avoidable uncertainty. When genetic risks remain unidentified, the consequences can include emotional strain and complex care journeys.

Whole Genome Sequencing (WGS) offers a paradigm shift. Investing in comprehensive data today allows resources to be channelled towards precise, evidence-based interventions rather than dispersed across broader, less targeted care
pathways.

Read: https://geknowmics.karkinos.in/2026/02/18/when-one-genome-test-changes-everything/

26/03/2026

Whole Genome Sequencing (WGS) acts as a safety blueprint. By identifying these markers early, clinicians can optimise dosage and personalise treatment plans to ensure the highest standards of patient safety and efficacy.

Read more: https://geknowmics.karkinos.in/2026/02/03/beyond-brca-what-a-major-indian-study-reveals-about-hidden-genetic-risks-in-breast-cancer/

25/03/2026

Standard biopsies provide a single snapshot, whereas cancer is dynamic. For many, the uncertainty of how a tumour is responding to treatment can be a significant challenge throughout the journey.

Discover how NGS-powered liquid biopsies are overcoming the limitations of invasive sampling, allowing clinicians to track tumour evolution in real-time through a simple blood sample. By monitoring these genetic shifts, we can ensure that treatment remains as dynamic and adaptive as the cancer itself.

Read more: https://geknowmics.karkinos.in/2026/01/21/tumor-genetics-explained-how-your-cancers-dna-guides-treatment/

Tumor Genetics Explained: How Your Cancer’s DNA Guides Treatment Posted on January 21, 2026January 17, 2026 by Editor Cancer is not just one disease. Even two people with the “same” cancer type—such as breast cancer or lung cancer—can have very different cancers at the genetic level. That ...

21/03/2026

Eid Mubarak from Karkinos Healthcare!
Wishing you a season of peace, prosperity, and the enduring gift of good health.

19/03/2026

May the season bring an abundance of happiness and prosperity to you and your loved ones.

Warm wishes for a joyful Ugadi and Gudi Padwa filled with good health and positivity!

18/03/2026

Traditional guidelines often rely on family history, which can be an incomplete map. Whole Genome Sequencing (WGS) provides a comprehensive view, identifying these hidden risks to ensure that every patient and their family—receives the life-saving preventive care they need.

17/03/2026

Karkinos Healthcare recently participated in the 8th National Conference of the Indian Society for Primary Immune Deficiency, a premier forum for clinicians, immunologists, and geneticists specialising in inborn errors of immunity and rare diseases.

The event facilitated dialogue with clinical leaders on the need for precision tools and early interventions in managing complex genetic disorders. These discussions underscored the role of our integrated genomics capabilities—specifically Whole Genome Sequencing (WGS), underpinned by high-throughput sequencing platforms, robust bioinformatics workflows, and structured clinical reporting frameworks.

By bridging the gap between advanced research and clinical application, we continue to strengthen the delivery of genomics-led diagnostics.